SEPTEMBER 11, 2006
RBC Capital Keeps Outperform on Genentech
Analyst Jason Kantor says the news about Avastin for breast cancer is clearly negative, and removes a significant growth driver in 2007
SEPTEMBER 11, 2006
Morgan Keegan Downgrades True Religion Apparel
Analyst Brad Stephens says the downgrade is based on both valuation and his belief that the company's strategic review will result in an event other than an outright sale
SEPTEMBER 7, 2006
Citigroup Cuts Martek Biosciences to Hold
Analyst Elise Wang says reduced gross margins and continuing idle manufacturing capacity costs will exert significant pressure on the bottom line well into next fiscal year
SEPTEMBER 6, 2006
Prudential Cuts Tanox to Underweight
Analyst Ron Ellis says the downgrade is based on valuation, higher expenses, and difficulty in identifying a commercial partner in HIV for the company's TNX-355 drug
SEPTEMBER 6, 2006
JP Morgan Upgrades NetFlix to Overweight
Analyst Barton Crockett says he believes investors are overly concerned about growth risks tied to technology change
SEPTEMBER 6, 2006
Citigroup Cuts Sunoco, Valero Energy to Hold
Analyst Doug Leggate says the downgrades reflect ongoing margin weakness and his view that second-half earnings per share may fall below consensus forecasts
=Subscribers Only
Copyright 2005, Bloomberg L.P.